ATE34770T1 - Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie. - Google Patents

Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.

Info

Publication number
ATE34770T1
ATE34770T1 AT84301997T AT84301997T ATE34770T1 AT E34770 T1 ATE34770 T1 AT E34770T1 AT 84301997 T AT84301997 T AT 84301997T AT 84301997 T AT84301997 T AT 84301997T AT E34770 T1 ATE34770 T1 AT E34770T1
Authority
AT
Austria
Prior art keywords
replication
origin
copy number
promoter
takes place
Prior art date
Application number
AT84301997T
Other languages
English (en)
Inventor
Geoffrey Thomas Yarranton
Gwynfor Owen Humphreys
Martyn Kim Robinson
Celia Ann Caulcott
Edwina Mary Wright
Original Assignee
Celltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Ltd filed Critical Celltech Ltd
Application granted granted Critical
Publication of ATE34770T1 publication Critical patent/ATE34770T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • C12N9/1033—Chloramphenicol O-acetyltransferase (2.3.1.28)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/69—Increasing the copy number of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT84301997T 1983-03-25 1984-03-23 Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie. ATE34770T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838308236A GB8308236D0 (en) 1983-03-25 1983-03-25 Dna vectors
EP84301997A EP0121386B1 (de) 1983-03-25 1984-03-23 DNA-Vektoren und ihre Verwendung in der rekombinanten DNA-Technologie

Publications (1)

Publication Number Publication Date
ATE34770T1 true ATE34770T1 (de) 1988-06-15

Family

ID=10540205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84301997T ATE34770T1 (de) 1983-03-25 1984-03-23 Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.

Country Status (8)

Country Link
US (1) US5015573A (de)
EP (1) EP0121386B1 (de)
JP (2) JPH0634721B2 (de)
AT (1) ATE34770T1 (de)
AU (1) AU565352B2 (de)
DE (2) DE121386T1 (de)
GB (2) GB8308236D0 (de)
WO (1) WO1984003713A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753111B2 (ja) * 1982-09-16 1995-06-07 ベンツォン ファーマ エイ／エス 条件非制御の複製挙動を持つプラスミド
US4710473A (en) * 1983-08-10 1987-12-01 Amgen, Inc. DNA plasmids
HU194307B (en) * 1983-09-16 1988-01-28 Richter Gedeon Vegyeszet Process for producing plasmidvectors of high copy number
US5240837A (en) * 1987-02-19 1993-08-31 The Upjohn Company CDNAS encoding somatotropin, expression vectors and hosts
WO1988006186A2 (en) * 1987-02-19 1988-08-25 The Upjohn Company cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
US4966841A (en) * 1987-05-22 1990-10-30 The Board Of Regents Of The University Of Washington Enhanced vector production and expression of recombinant DNA products
EP0393045B1 (de) * 1987-09-09 1995-03-29 Celltech Therapeutics Limited Fv Antikörperfragment-Herstellung
GB8819135D0 (en) * 1988-08-11 1988-09-14 Celltech Ltd Tryptophan production
FI88309C (fi) 1989-04-20 1993-04-26 Bio Orbit Oy Ny biotest
GB9215541D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9215540D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9215550D0 (en) * 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
GB9518395D0 (en) * 1995-09-08 1995-11-08 Therexsys Ltd Plasmid stabilization
US6743780B1 (en) 1995-09-08 2004-06-01 Cobra Biologics Limited Plasmid stabilization
US6165749A (en) 1996-03-13 2000-12-26 Takara Shuzo Co., Ltd. Plasmid
US6747129B1 (en) * 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
AU1031900A (en) * 1998-11-09 2000-05-29 Genecare Development Aps Novel plasmids for use in medicine and method of producing same
US6780405B1 (en) 2000-04-28 2004-08-24 Avant Immunotherapeutics, Inc. Regulated antigen delivery system (RADS)
US7575924B2 (en) 2000-11-13 2009-08-18 Research Development Foundation Methods and compositions relating to improved lentiviral vectors and their applications
US20040137003A1 (en) * 2001-04-30 2004-07-15 Curtiss Iii Roy Regulated antigen delivery system (rads)
ATE527347T1 (de) 2001-08-02 2011-10-15 Inst Clayton De La Rech Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
RU2305708C2 (ru) 2001-10-02 2007-09-10 Энститю Клейтон Де Ля Решерш Рекомбинантный лентивирусный вектор, клетка-хозяин, трансдуцированная лентивирусным вектором, способ ее трансдукции и применение
US20050014166A1 (en) * 2002-11-22 2005-01-20 Institut Clayton De La Recherche Compositions and systems for the regulation of genes
WO2004078965A1 (ja) * 2003-03-05 2004-09-16 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 大腸菌における異種蛋白質の製造方法
US7794971B1 (en) 2003-07-01 2010-09-14 Epicentre Technologies Corporation Compositions and methods for controlling copy number for a broad range of plasmids and uses thereof
DE112004001695T5 (de) * 2003-09-11 2006-07-06 Advantest Corp. Vorrichtung zur Erzeugung eines Fehlerkorrektursignals und ein Quadraturmodulator, der mit der Vorrichtung zur Erzeugung eines Fehlerkorrektursignals ausgerüstet ist
AU2005212237B2 (en) * 2004-02-04 2009-06-11 Merck Sharp & Dohme Llc Process for large scale production of plasmid DNA by E. coli fermentation
EP1745068A4 (de) * 2004-03-30 2009-11-04 Sudershan Biotech Ltd Rekombinantes kalbschymosin und herstellungsverfahren dafür
US8999672B2 (en) 2005-01-28 2015-04-07 James A. Williams Compositions and processes for improved plasmid DNA production
US8916376B2 (en) * 2007-05-15 2014-12-23 Biotex, Inc. Metal-binding peptides
EA201591324A1 (ru) 2013-01-16 2016-01-29 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Полипептид растворимого рецептора 3 фактора роста фибробластов (fgr3) для применения с целью предотвращения или лечения нарушений, связанных с замедлением роста скелета
UY35368A (es) * 2013-03-08 2014-10-31 Irm Llc Péptidos y composiciones para el tratamiento de daño articular
MA38369B1 (fr) 2013-03-08 2018-10-31 Novartis Ag Peptides et compositions pour le traitement d'une lesion de l'articulation
US9840557B2 (en) * 2014-09-23 2017-12-12 Regeneron Pharmaceuticals, Inc. Anti-IL-25 antibodies and uses thereof
EP3242888B8 (de) * 2015-01-07 2021-06-02 Pfizer Inc. Lösliche fgfr3-köder zur behandlung von wachstumsstörungen
MX2018016257A (es) 2016-07-07 2019-11-21 Therachon Sas Polipéptidos del receptor 3 del factor de crecimiento de fibroblastos solubles (sfgfr3) y usos de los mismos.
PE20210313A1 (es) * 2018-03-28 2021-02-12 Bristol Myers Squibb Co Proteinas de fusion interleucina-2/receptor alfa de interleucina-2 y metodos de uso
TW202027794A (zh) 2018-10-03 2020-08-01 瑞士商諾華公司 血管生成素樣３多肽之持續遞送
CA3185855A1 (en) * 2020-06-05 2021-12-09 Modernatx, Inc. Bacterial strains for dna production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2759053A1 (de) * 1977-12-30 1979-07-12 Uhlin Verfahren zum herstellen von genprodukten von plasmid-dns
CA1198067A (en) * 1981-02-27 1985-12-17 David H. Gelfand Stable high copy number plasmids
CA1198069A (en) * 1982-06-08 1985-12-17 David H. Gelfand Temperature sensitive multicopy plasmids
US4806471A (en) * 1982-09-16 1989-02-21 A/S Alfred Benzon Plasmids with conditional uncontrolled replication behavior

Also Published As

Publication number Publication date
JPH0634721B2 (ja) 1994-05-11
WO1984003713A1 (en) 1984-09-27
US5015573A (en) 1991-05-14
EP0121386A1 (de) 1984-10-10
AU565352B2 (en) 1987-09-10
AU2812484A (en) 1984-10-09
DE121386T1 (de) 1985-05-23
JPH06315388A (ja) 1994-11-15
EP0121386B1 (de) 1988-06-01
GB2136814B (en) 1987-05-28
GB8407572D0 (en) 1984-05-02
GB8308236D0 (en) 1983-05-05
DE3471688D1 (en) 1988-07-07
GB2136814A (en) 1984-09-26
JPS60501837A (ja) 1985-10-31
JPH07114703B2 (ja) 1995-12-13

Similar Documents

Publication Publication Date Title
ATE34770T1 (de) Dna-vektoren und ihre verwendung in der rekombinanten dna-technologie.
MX9606476A (es) Inhibicion citoplasmica de expresion de genes.
EP0260148A3 (de) Rekombinantes Expressionsverfahren, Vektor und tranformierte Zellen
ATE64416T1 (de) Die verwendung des gal 1 hefe-promotors.
DK0770136T3 (da) Fremgangsmåde til at selektere höjtudtrykkende værtsceller
NO950534L (no) Modufiserte soppceller og fremgangsmåter for fremstilling av rekombinante produkter
CL2009002108A1 (es) Secuencia de adn que codifica una de secuencia aminoacidos con actividad farnesil pirofosfato sintetasa; vector que comprende dicha secuencia; celula huesped transformada con dicha secuencia; proceso de produccion de enzima para convertir isopentil pirofosfato a farnesil pirofosfato; y proceso para producir astaxantina (div. sol. no 891-99).
DK0864645T3 (da) Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
ES2013324A6 (es) Un metodo mejorado para producir una proteina heterologa.
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
ATE286126T1 (de) Glialmitogene faktoren, ihre herstellung und verwendung
DK0863202T3 (da) Rekombinant Sendai-virus
SG141233A1 (en) Control of gene expression
BG60107B2 (bg) Метод за получаване на еукариотен полипептид
DK0663921T3 (da) Fremgangsmåde til forøgelse af ekspression og reduktion af ekspressionsvariabilitet af fremmede gener i planteceller
FI941947A0 (fi) Rekombinantti-core-streptavidiini
Thormar A Comparison of Visna and Maedi Viruses: I.—Physical, Chemical and Biological Properties
KR880010126A (ko) 펙틴 라이에이즈 발현 시스템을 암호화하는 dna 서열을 함유하는 재조합 dna 분자 및 이의 제조방법
ATE192499T1 (de) Herstellung rekombinanter proteine unter verwendung von herpes-virus-promotoren und vp16- transaktivatoren
DE69734512D1 (de) Steigerung der genexpression
NO924576D0 (no) Kloning og ekspresjon av gener som koder for arabinan-nedbrytende enzymer av sopp-opprinnelse
DK0843731T3 (da) Adenovirusvektorer til genterapi
DK160947C (da) Gen-udtrykkelsessystem
Schwartz Genetic studies on mutant enzymes in maize, V. in vitro interconversion of allelic isozymes
ATE72837T1 (de) Vielfach amplifizierbare vektoren fuer hohe expression exogener dns.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time